[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Armed Forces Hospital, Pakistan\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":65},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,40],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100589725",false,"NCT06958146","Azithromycin for Preventing Maternal and Neonatal Infections During Labor.","Impact of Single Dose Azithromycin During Labor on Maternal and Neonatal Infections","Inclusion Criteria:\n\n* pregnant ladies with no risk factors for sepsis who go into spontaneous labor or induced labor\n\nExclusion Criteria:\n\n* pregnant with risk factors for sepsis like maternal fever , raised WBC count, chorioamnionitis, or having. history of any adverse even with macrolides","FEMALE","18 Years","45 Years",{"count":19,"type":20},400,"ESTIMATED","INTERVENTIONAL",[23],"PHASE4","In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother",[26,27],"Maternal and Neonatal Sepsis","Intrapartum Antibiotics","NOT_YET_RECRUITING","2025-04-28",{"date":31,"type":32},"2025-05-06","ACTUAL",{"date":34,"type":20},"2025-05-01",{"date":36,"type":20},"2025-08-31",{"name":38,"class":39},"Armed Forces Hospital, Pakistan","OTHER",{"id":41,"slug":4,"hasResults":10,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":10,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":4,"studyType":21,"phases":50,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100556244","NCT06522581","Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy","Inclusion Criteria:\n\n1. all indoor newborn babies with HIE II and III\n2. who have not received therapeutic hypothermia\n\nExclusion Criteria:\n\n1. grade I HIE\n2. Babies on TH\n3. babies whose parents do not give consent for inclusion in study\n4. babies with major congential malformations -","ALL","1 Day","30 Days",{"count":49,"type":20},200,[51],"PHASE1","Hypoxic ischemic encephalopathy is an acute or subacute brain injury, due to asphyxia in neonates, leading to mortality and long-term morbidity. Its prevalence varies across regions, with developed countries reporting rates of 1.5 per 1000 live births, while developing nations experience a wider range from 2.3 to 26.5 per 1000 live births.\n\nInfants afflicted with moderate HIE face a 10% risk of mortality, with surviving individuals encountering a 30% chance of developing disabilities. The prognosis is graver for severe HIE, with a mortality risk of 60%, and nearly all survivors experiencing some form of disability.",[54],"Hypoxic Ischemic Encephalopathy of Newborn","RECRUITING","2024-08-12",{"date":58,"type":32},"2024-08-14",{"date":60,"type":32},"2024-01-01",{"date":62,"type":20},"2025-01-01",{"name":38,"class":39},1,""]